Skip to main content

and
  1. Article

    Open Access

    Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome

    Anti-Jo-1 autoantibodies represent essential markers in the diagnosis of antisynthetase syndrome (ASS). In this retrospective study, we aimed to investigate whether their concentrations and fluctuations could ...

    Robin Arcani, Louise Rey, Alice Mazziotto, Daniel Bertin in Arthritis Research & Therapy (2023)

  2. No Access

    Article

    Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures

    Patients with systemic lupus erythematosus (SLE) display symptoms that are not always related to disease activity and may distort clinical trial results. Recently, a clinical categorization based on the prese...

    Robin Arcani, Elisabeth Jouve, Laurent Chiche in Clinical Rheumatology (2023)

  3. No Access

    Article

    Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis

    Systemic sclerosis (SSc) is a complex autoimmune disease characterized by a functional and structural alteration of the microvascular network associated with cutaneous and visceral fibrosis lesions. Convention...

    Mélanie Velier, Aurélie Daumas, Stéphanie Simoncini in Bone Marrow Transplantation (2022)

  4. Article

    Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue

    Specificities of COVID-19 disease course in patients with haematologic malignancies are still poorly studied. So, we aimed to compare patients with haematologic malignancies to patients without malignancies, m...

    Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi in Annals of Hematology (2021)

  5. Article

    Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes

    Florian Correard, Anne-Laure Couderc, Robin Arcani, Joris Weiland in Drugs & Aging (2021)